Writing the Next Chapter in Precision Medicines

Discovering and developing the next generation of precision medicines through:

Industry leaders with a proven track record of success

Building a broad pipeline of potentially best-in-class therapies

News

August 4, 2026
OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights
July 2, 2026
OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026
May 5, 2026
OnKure Therapeutics Reports First Quarter 2026 Financial Results
View All News